Opinion: Is it time for big biopharma companies to rethink the use of federal funding for R&D?
I have been negotiating with representatives of the federal government on behalf of biopharmaceutical companies…
Author: STAT
Opinion: Uncorking today’s Covid-19 supply chain to meet the challenges of future pandemics
At what point do the benefits of local production of medical supplies outweigh the potentially…
U.S. would seek global approach to updating Covid-19 vaccines, official says
If the Food and Drug Administration decides to update Covid-19 vaccines to take better aim…
STAT+: Wary of a backlash, telehealth startups focused on women’s sexual health steer clear of abortion pills
The online pharmacy Nurx advertises itself as the company that “gives women sexual freedom.” Hims…
STAT+: Real estate developer reneges on multimillion-dollar pledge to Harvard-led Covid project
A financially troubled Chinese real-estate developer has reneged on a major pledge to Harvard University, leaving…
At Davos, a ‘good news, bad news’ message emerges about Covid-19
As the coronavirus continues to wreak havoc, an expert panel at the World Economic Forum…
Opinion: Fighting Covid-19 in Kibera, one of Africa’s largest informal settlements
KIBERA, Kenya — Nearly 10 months after a grandmother in England became the first person…
CDC encourages more Americans to consider N95 masks
NEW YORK (AP) — U.S. health officials on Friday encouraged more Americans to wear the…
STAT+: Martin Shkreli is ordered to pay $64 million and is banned from the pharma industry for life
“Pharma bro” Martin Shkreli was ordered to pay $64 million in profits and was banned…
Opinion: Eliminating the FDA’s blood donation ban on men who have sex with men would help ease the U.S. shortage
For the first time ever, the American Red Cross this week declared a national blood…
STAT+: Pharmalittle: Senate committee advances Califf FDA nomination; bedraggled Biogen writes a shopping list
And so, another working week will soon draw to a close. Not a moment too…
Opinion: Public health is missing crucial data on LGBTQIA+ people. It’s not hard to collect
The importance of capturing demographic data in health care settings and population surveys can’t be…
Opinion: STAT+: Patient engagement: The true benchmark in clinical trials
Patient engagement and community outreach may be hot topics in today’s clinical trial landscape, but…
No one has any idea how much money seniors could pay for new Alzheimer’s drug
WASHINGTON — Medicare has outlined how it plans to cover the controversial, pricey new Alzheimer’s treatment…
Scientists are making CAR-T cells more clever. Here’s what the next generation could look like
CAR-T cell therapy has been a boon for treating blood cancers. Since the technology was…
Listen: #JPM22 in review, Biogen’s worsening fortunes, & the future of RNA drugs
Was J.P. Morgan a drag? Is it time to give up on Aduhelm? And how…
Supreme Court halts Covid-19 vaccine rule for U.S. businesses
WASHINGTON — The Supreme Court has stopped the Biden administration from enforcing a requirement that…
STAT+: With its Alzheimer’s drug in turmoil, Biogen eyes a list of potential acquisitions
Biogen, desperate to reverse the turmoil surrounding its controversial Alzheimer’s treatment Aduhelm, has a shopping…
Strong new evidence suggests a virus triggers multiple sclerosis
If you were to ask any of the 1 million Americans living with multiple sclerosis,…
STAT+: FDA warns Chinese manufacturer for lack of vision when making sterile eye drops
When it comes to making eye drops, one Chinese manufacturer failed to clearly see the…
With its Aduhelm proposal, Medicare is stepping into a heated debate about how best to improve equity in Alzheimer’s treatment
WASHINGTON — Medicare’s proposal to restrict access to a controversial Alzheimer’s drug has quickly reignited…
Telehealth experiments & the latest digital health news from JPM
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
Unvaccinated pregnant people are at higher risk for Covid complications and newborn deaths
Unvaccinated pregnant people who get Covid-19 are at much higher risk for complications from the…
STAT+: Pharmalittle: Lilly and Roche are also losers in the Medicare Alzheimer’s decision; former CRO owner pleads guilty to falsifying data
Rise and shine, another busy day is on the way. However, this is also shaping…
Opinion: The solution to the wave of nurse resignations? Cold, hard cash
It’s been said so often it’s almost trite: Burnout among nurses drags down hospitals’ quality…
Opinion: Many doctors are still befuddled by accommodating people with disability
Shortly after one of my younger sisters was diagnosed with breast cancer in her early…
STAT+: A new biotech startup looks to sidestep a key problem with CAR-T cancer therapies
There are two things Phil Greenberg, the head of immunology at Fred Hutchinson Cancer Research…
A cascade of Omicron-driven shortages puts U.S. hospitals in a bind
The Covid-19 medications are supposed to keep people out of the hospital — and to…
STAT+: Telehealth companies are testing the waters with taking on more risk
A handful of telehealth companies are dipping into payment systems that reward them for keeping…
In a battle over the future of U.S. health care, a question emerges: Is primary care scalable?
The J.P. Morgan Healthcare Conference is a place for the well-heeled to get a readout…
Researchers shatter the speed record for diagnosing rare genetic diseases with DNA sequencing
About a year ago, Matthew Kunzman’s heart was failing, despite doctors’ best attempts to bolster…
STAT+: The biggest losers from Medicare’s decision on Aduhelm may be Biogen’s competitors
Medicare may have released a plan to restrict access to Biogen’s controversial Alzheimer’s drug, but…
STAT+: Why Biogen’s Medicare mess is bad for the pharmaceutical industry
Medicare’s proposal that it will cover Alzheimer’s drugs such as Biogen’s embattled Aduhelm only in…
STAT+: Pharmalittle: Medicare proposes to restrict coverage of Biogen Alzheimer’s drug; Pfizer to cut its U.S. sales staff
Hello, everyone, and welcome to the middle of the week. You made it this far,…
Opinion: The crazy confluence of Congress, liquid biopsies, Medicare, and health inequities
It would be crazy for members of Congress to introduce a bill mandating that Medicare…
Opinion: Trusting relationships are the core of medicine. Can telehealth support them?
A number of promising new digital health companies have surfaced in the past two years,…
STAT+: As surges drive Covid-19 testing, companies eye an on-ramp for new markets
Throughout the pandemic, companies big and small have responded to the call for widely available…
Jolting the brain’s circuits with electricity is moving from radical to almost mainstream therapy. Some crucial hurdles remain
In June 2015, biology professor Colleen Hanlon went to a conference on drug dependence. As…
STAT+: ‘Skinny label’ for generic version of a pricey cancer drug cut costs for consumers
After a ‘skinny label’ was used to market a generic version of a pricey brand-name…
Medicare plans to restrict access to controversial, pricey Alzheimer’s drug Aduhelm to patients in clinical trials
WASHINGTON — Medicare plans to cover the controversial, pricey Alzheimer’s drug Aduhelm, but only for…
Opinion: You’d expect health care workers on the Covid frontlines to be tested regularly. You’d be wrong
“Have they stopped caring about our health?” reads a text from my friend and fellow…
Virtual Event – [email protected]: Will 2022 bring biotech renewal?
Editor’s note: A livestream of this event will be embedded below at 1:00 p.m. ET….
Health tech M&A is heating up
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: Pharmalittle: Biogen CEO admits Alzheimer’s drug price was ‘wrong’; Becerra orders HHS to reconsider Medicare premium hike
Rise and shine. Another busy day is on the way. And it appears to be…
STAT+: Amgen, Arrakis Therapeutics partner to develop oral drugs that eliminate troublesome RNA
Amgen and the biotech startup Arrakis Therapeutics announced a research collaboration Tuesday to discover and…
Opinion: AMA’s new language guide is a step toward health equity
In the early 1990s, 10 Black children were treated for severe third-degree burns in a…
Opinion: Active surveillance for prostate cancer: The gift that keeps on giving
In the run-up to the holidays 11 years ago, a doctor gave me a gift…
13 big questions about Biden’s response to Omicron, as Congress prepares to grill Fauci, Walensky, and other top officials
Amid another coronavirus surge, and facing pressure over everything from testing access to school closures,…
‘I’m going to prove you wrong’: How a D.C. power couple used an ALS diagnosis to create a political juggernaut
KENILWORTH, Ill. — When her husband first floated the idea of an advocacy organization for…
First transplant of a genetically altered pig heart into a person sparks ethics questions
A medical team at the University of Maryland Medical Center announced Monday that it had…